A Study of XmAb20717 in Subjects With Selected Advanced Solid Tumors
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
This is a Phase 1, multiple dose, ascending dose escalation study to define a MTD/RD and regimen of XmAb20717, to describe safety and tolerability, to assess PK and immunogenicity, and to preliminarily assess anti-tumor activity of XmAb20717 in subjects with selected advanced solid tumors.
创建时间：
2018-07-15
